REN001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REN001, covering 2024-05-28 to 2024-05-28. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead) [Phase 2, Phase 3]